SALBUTAMOL TEVA 2.5 mg/2.5 ml, solution for inhalation by nebulizer in a single-dose container 60 single-dose containers of 2.5 ml
Active ingredients: Salbutamol, Albuterol sulfate
Commercialized according to BDPMDispensing in France: Prescription only
Solution for inhalation by nebulizer60 single-dose containers of 2.5 mlinhalée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SALBUTAMOL TEVA 2,5 mg/2,5 mL, solution pour inhalation par nébuliseur en récipient unidose
- Pharmaceutical form
- solution pour inhalation par nébuliseur
- Route of administration
- inhalée
- Presentation description
- 60 récipient(s) unidose(s) polyéthylène basse densité (PEBD) de 2,5 ml
- Marketing authorisation holder
- TEVA SANTE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 14 Aug 2009
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by specialists only
- Emergency use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68036348CIP73895368CIP133400938953688Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SALBUTAMOLsolution | 2,5 mg · un récipient unidose de 2,5 ml | FT |
| SULFATE DE SALBUTAMOLsolution | 3 mg · un récipient unidose de 2,5 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.